These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36416305)
1. Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B. Argyris PP; Naumann J; Jarvis MC; Wilkinson PE; Ho DP; Islam MN; Bhattacharyya I; Gopalakrishnan R; Li F; Koutlas IG; Giubellino A; Harris RS Histopathology; 2023 Mar; 82(4):608-621. PubMed ID: 36416305 [TBL] [Abstract][Full Text] [Related]
2. Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers. Argyris PP; Wilkinson PE; Jarvis MC; Magliocca KR; Patel MR; Vogel RI; Gopalakrishnan R; Koutlas IG; Harris RS Mod Pathol; 2021 Feb; 34(2):280-290. PubMed ID: 32632179 [TBL] [Abstract][Full Text] [Related]
3. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B. Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B. Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS mBio; 2014 Dec; 5(6):. PubMed ID: 25538195 [TBL] [Abstract][Full Text] [Related]
5. APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity. Ma W; Ho DW; Sze KM; Tsui YM; Chan LK; Lee JM; Ng IO Mol Carcinog; 2019 May; 58(5):643-653. PubMed ID: 30575099 [TBL] [Abstract][Full Text] [Related]
6. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1. McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276 [TBL] [Abstract][Full Text] [Related]
7. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells. Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745 [TBL] [Abstract][Full Text] [Related]
8. Black and Brown Oro-facial Mucocutaneous Neoplasms. Natarajan E Head Neck Pathol; 2019 Mar; 13(1):56-70. PubMed ID: 30693458 [TBL] [Abstract][Full Text] [Related]
9. Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells. Yamazaki H; Shirakawa K; Matsumoto T; Hirabayashi S; Murakawa Y; Kobayashi M; Sarca AD; Kazuma Y; Matsui H; Maruyama W; Fukuda H; Shirakawa R; Shindo K; Ri M; Iida S; Takaori-Kondo A Sci Rep; 2019 May; 9(1):7122. PubMed ID: 31073151 [TBL] [Abstract][Full Text] [Related]
10. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells. Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation. Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764 [TBL] [Abstract][Full Text] [Related]
13. ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells. Kazuma Y; Shirakawa K; Tashiro Y; Yamazaki H; Nomura R; Horisawa Y; Takeuchi S; Stanford E; Konishi Y; Matsui H; Matsumoto T; Tanabe F; Morishita R; Ito S; Takaori-Kondo A Sci Rep; 2022 Feb; 12(1):2278. PubMed ID: 35145187 [TBL] [Abstract][Full Text] [Related]
14. m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis. Gao M; Qi Z; Feng W; Huang H; Xu Z; Dong Z; Xu M; Han J; Kloeber JA; Huang J; Lou Z; Liu S J Biol Chem; 2022 Feb; 298(2):101563. PubMed ID: 34998823 [TBL] [Abstract][Full Text] [Related]
15. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle. Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502 [TBL] [Abstract][Full Text] [Related]
16. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells. Maruyama W; Shirakawa K; Matsui H; Matsumoto T; Yamazaki H; Sarca AD; Kazuma Y; Kobayashi M; Shindo K; Takaori-Kondo A Biochem Biophys Res Commun; 2016 Sep; 478(3):1466-71. PubMed ID: 27577680 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B. Roelofs PA; Goh CY; Chua BH; Jarvis MC; Stewart TA; McCann JL; McDougle RM; Carpenter MA; Martens JW; Span PN; Kappei D; Harris RS Elife; 2020 Sep; 9():. PubMed ID: 32985974 [TBL] [Abstract][Full Text] [Related]
18. APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner. Bandarra S; Miyagi E; Ribeiro AC; Gonçalves J; Strebel K; Barahona I J Virol; 2021 Nov; 95(23):e0117021. PubMed ID: 34523960 [TBL] [Abstract][Full Text] [Related]
19. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population. Liu HG; Kong MX; Yao Q; Wang SY; Shibata R; Yee H; Martiniuk F; Wang BY Head Neck Pathol; 2012 Dec; 6(4):401-8. PubMed ID: 22736149 [TBL] [Abstract][Full Text] [Related]
20. APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers. Tsuboi M; Yamane A; Horiguchi J; Yokobori T; Kawabata-Iwakawa R; Yoshiyama S; Rokudai S; Odawara H; Tokiniwa H; Oyama T; Takeyoshi I; Nishiyama M Breast Cancer; 2016 Sep; 23(5):780-8. PubMed ID: 26476745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]